J&J Cash Can't Sway Medicine's High Priests, Surgeon Says
A heart surgeon testifying Wednesday for Johnson & Johnson in Oklahoma's landmark opioid-crisis trial rejected the possibility that doctors could have been swayed by the company's $30 million annual marketing budget...To view the full article, register now.
Already a subscriber? Click here to view full article